Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. - Wikidata - wikimedia - TriplyDB

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.

http://www.wikidata.org/entity/Q37580870

about

[Choosing wisely recommendations in cardiology].Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk Individuals.

P2860

Q30313178-B129A482-D5F6-4505-9971-7E5DAF1885F9 Q38825508-4BA198A5-EF11-4D62-AE80-9C384B7297A2 Q52607834-D391CDEE-1A97-4E1E-B0DF-8E9DEE7D8113

P2860

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.

http://www.wikidata.org/entity/Q37580870

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Personalized absolute benefit ...... n individual elderly patients.

@en

Personalized absolute benefit ...... n individual elderly patients.

@nl

type

label

Personalized absolute benefit ...... n individual elderly patients.

@en

Personalized absolute benefit ...... n individual elderly patients.

@nl

prefLabel

Personalized absolute benefit ...... n individual elderly patients.

@en

Personalized absolute benefit ...... n individual elderly patients.

@nl

P1433

Q37580870-095EA616-5041-4649-8075-4ECCAB793D14

P1476

Q37580870-BA484911-6286-4776-BCB5-B722144E809B

P2093

Q37580870-1036E793-CB82-4C4C-829D-059DF0B5047A

Q37580870-352D0D43-10C0-418D-B1B6-BCB06E4B4E64

Q37580870-41C3151B-9784-4FEA-871E-E2AC0D34C36C

Q37580870-4A1EBA56-1C5C-40B6-9377-7168F6941A40

Q37580870-5A0DD0B9-908B-4BD7-BC08-029C84B69017

Q37580870-60A515D0-75C9-427D-AAAA-76D9677E07DD

Q37580870-82C36F88-0AD3-46A7-AFA9-CC8EA0CB7BA3

Q37580870-A4CAC206-7D43-49BF-9398-CABF76300ADF

Q37580870-BAF4AAD5-32F5-4675-B020-1B8ABC22CB41

P2860

Q37580870-08B806A1-75D9-456D-AA8C-A0604B147DCB

Q37580870-133B579B-9339-4527-A66F-A9E3D14467B4

Q37580870-175698C2-2575-421C-A034-7E86C66AFC7D

Q37580870-2500FCFD-EC23-4ECB-AAF3-DFD5253A0624

Q37580870-269A1447-F492-4165-9E96-C4B8F4E0C897

Q37580870-42F85702-C7FA-4583-B038-C16C939B7E96

Q37580870-540F0F48-96A3-459B-8150-45E511AAA1C4

Q37580870-57760D17-6A88-494E-ADD6-FDF17165DADE

Q37580870-59B109C4-56E2-4B1B-A397-670D3C425726

Q37580870-5F3EA505-B27A-45FF-9F71-2FDD14CF934C

P2888

Q37580870-FEAC7D56-22AD-461F-9F75-912280F194DD

P304

Q37580870-5F45A19A-A80D-495A-B768-A49D5908AA50

P31

Q37580870-68DD294C-A499-4FF3-B31F-6AA3E72CC102

P356

Q37580870-360F7355-6C2F-4BF9-8D16-C9152C19BE22

P433

Q37580870-EFF9B6E9-67B5-4987-9CD9-DC6008A5C4BE

P478

Q37580870-CF9240AA-D86D-4F72-9D17-C0CE05B8E089

P50

Q37580870-4FD7930F-C4CA-4F89-8358-1524EF702D4F

Q37580870-E0275947-869D-4DE4-86FF-D7D9E3EC8D77

P577

Q37580870-6B3DF06A-7160-40F6-9C63-F79968472CF5

P698

Q37580870-5AE5D740-F49C-4A75-875D-747B8EF19A09

P932

Q37580870-05325069-CCF9-4DED-8414-1A5ACEFC0074

P356

S00392-016-1023-8

P1433

Clinical Research in Cardiology

P1476

Personalized absolute benefit ...... n individual elderly patients.

@en

P2093

Ajay Gupta

http://www.w3.org/2001/XMLSchema#string

Anton J M de Craen

http://www.w3.org/2001/XMLSchema#string

Frank L J Visseren

http://www.w3.org/2001/XMLSchema#string

J Wouter Jukema

http://www.w3.org/2001/XMLSchema#string

Manon C Stam-Slob

http://www.w3.org/2001/XMLSchema#string

Neil R Poulter

http://www.w3.org/2001/XMLSchema#string

Patricia M Kearney

http://www.w3.org/2001/XMLSchema#string

Peter W Macfarlane

http://www.w3.org/2001/XMLSchema#string

Yolanda van der Graaf

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

Statins for primary cardiovascular prevention in the elderly

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Adherence to Medication

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

The burden of disease in older people and implications for health policy and practice.

Method for evaluating prediction models that apply the results of randomized trials to individual patients

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

P2888

s00392-016-1023-8

P304

58-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00392-016-1023-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27554244

http://www.w3.org/2001/XMLSchema#string

P932

5226996

http://www.w3.org/2001/XMLSchema#string